A180 Advocin 50ml

Product Description

Use of this product on farms is restricted and should only be used as last resort. Please speak to your vet for further guidance.

Advocin 180 contains danrofloxacin and is specifically indicated for the treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni and for the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin in cattle and calves. 

Advocin 180 is also indicated for the treatment of enteric (gut) infections caused by Escherichia coli sensitive to danofloxacin in neonatal calves.

Dosage & Administration

6 mg/kg body weight (1 ml/30 kg body weight) as a single injection by the subcutaneous or intravenous route.

If clinical signs of respiratory or enteric disease persist 48 hours after the first injection, an additional dose at 6 mg/kg body weight may be administered. It is recommended to treat animals in the early stages of disease and to evaluate the response to treatment within 48 hours.

For the treatment of acute bovine mastitis, Advocin 180 should be administered at 6 mg/kg body weight (1 ml/30kg body weight) as a single injection by the subcutaneous or intravenous route. The clinical signs should be monitored carefully and supportive therapy should be given as appropriate. If clinical signs of acute bovine mastitis persist 36-48 hours after the first injection, the antibiotic treatment should be reviewed. It is recommended to treat animals in the early stages of disease and to evaluate the response to treatment within 36-48 hours.

For treatment of cattle weighing more than 450 kg, divide the subcutaneous dose so that no more than 15 ml are injected at one site. When dosing a large number of animals from a single vial, the use of an automatic syringe is recommended to avoid excessive broaching of the rubber stopper.